HALE BIOPHARMA VENTURES LLC has a total of 19 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Canada. Its main competitors in its focus markets pharmaceuticals and medical technology are ABSORPTION PHARMACEUTICALS LLC, GW PHARMA LTD and US WORLDMEDS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Japan | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Cartt Steve | 17 |
#2 | Medeiros David | 16 |
#3 | Mitchnick Mark | 13 |
#4 | Loxley Andrew | 13 |
#5 | Gwozdz Garry Thomas | 12 |
#6 | Hale David | 11 |
#7 | Maggio Edward T | 10 |
#8 | Steve Cartt | 2 |
#9 | David Medeiros | 2 |
#10 | Garry Thomas Gwozdz | 2 |
Publication | Filing date | Title |
---|---|---|
US2014170220A1 | Multimodal particulate formulations | |
EP3415139A1 | Administration of benzodiazepine | |
US2009258865A1 | Administration of benzodiazepine compositions |